We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.05B
AUM Growth
-$342M
Cap. Flow
-$333M
Cap. Flow %
-8.21%
Top 10 Hldgs %
11.89%
Holding
2,058
New
529
Increased
346
Reduced
400
Closed
620

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 11.64%
3 Consumer Discretionary 10.2%
4 Industrials 7.56%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLW icon
1126
Corning
GLW
$136B
$247K 0.01%
+5,195
New +$246K
EOSE icon
1127
Eos Energy Enterprises
EOSE
$1.37B
$245K 0.01%
50,485
-31,525
-38% -$102K
TYRA icon
1128
Tyra Biosciences
TYRA
$1.56B
$244K 0.01%
+17,560
New +$319K
QUAD icon
1129
Quad
QUAD
$525M
$244K 0.01%
+34,979
New +$237K
ESS icon
1130
Essex Property Trust
ESS
$18.4B
$244K 0.01%
854
-804
-48% -$238K
LEU icon
1131
Centrus Energy
LEU
$3.71B
$243K 0.01%
+3,652
New +$285K
RHP icon
1132
Ryman Hospitality Properties
RHP
$8.12B
$243K 0.01%
+2,325
New +$259K
ALB icon
1133
Albemarle
ALB
$14.1B
$242K 0.01%
+2,811
New +$280K
MTB icon
1134
M&T Bank
MTB
$36.5B
$242K 0.01%
+1,285
New +$255K
XRAY icon
1135
Dentsply Sirona
XRAY
$2.76B
$241K 0.01%
+12,721
New +$269K
PB icon
1136
Prosperity Bancshares
PB
$8.94B
$241K 0.01%
+3,193
New +$247K
CTV.WS
1137
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$239K 0.01%
+77,385
New +$6.25K
SANA icon
1138
PUT
Sana Biotechnology
SANA
$968M
$238K 0.01%
146,200
-43,900
-23% -$131K
AMTM
1139
Amentum Holdings
AMTM
$5.73B
$237K 0.01%
+11,250
New +$291K
CPAY icon
1140
Corpay
CPAY
$25.6B
$237K 0.01%
699
-17,233
-96% -$6.06M
AVTR icon
1141
Avantor
AVTR
$9.07B
$237K 0.01%
11,225
-15,054
-57% -$339K
VMCAW
1142
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$236K 0.01%
20,497
LDOS icon
1143
Leidos
LDOS
$16.1B
$236K 0.01%
+1,639
New +$273K
CHH icon
1144
Choice Hotels
CHH
$5.09B
$236K 0.01%
+1,660
New +$235K
CMPS
1145
Compass Pathways
CMPS
$1.77B
$235K 0.01%
62,300
-14
-0% -$71
HST icon
1146
Host Hotels & Resorts
HST
$17.3B
$233K 0.01%
+13,317
New +$239K
MSGS icon
1147
Madison Square Garden
MSGS
$9.42B
$233K 0.01%
1,031
-1,188
-54% -$265K
ALGM icon
1148
Allegro MicroSystems
ALGM
$7.87B
$232K 0.01%
+10,628
New +$226K
EXPD icon
1149
Expeditors International
EXPD
$23.5B
$232K 0.01%
+2,095
New +$250K
KMI icon
1150
Kinder Morgan
KMI
$69.3B
$232K 0.01%
8,455
-3,248
-28% -$84.7K

Similar funds

Boothbay Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boothbay Fund Management held 2,058 positions worth $4.05B, down 7.8% from $4.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boothbay Fund Management withdrew a net $333M in Q4 2024, closing 620 positions and reducing 400 holdings. Its most notable exit was Nova Vision Acquisition Corp. Warrant, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Cardinal Health worth $10.8M.

  • Boothbay Fund Management's largest Q4 2024 buy was Cardinal Health: 91,430 shares worth $10.8M.
  • Boothbay Fund Management added most to Arthur J. Gallagher & Co in Q4 2024, an estimated $20M increase.
  • Boothbay Fund Management's biggest Q4 2024 reduction was Dell, cutting an estimated $36.8M.
  • Boothbay Fund Management fully exited Nova Vision Acquisition Corp. Warrant in Q4 2024, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 12% of its $4.05B portfolio in Q4 2024.
  • Boothbay Fund Management opened 529 new positions and closed 620 in Q4 2024.
  • Boothbay Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.05B.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.